₹18.5
▲ +0.75 +4.23%
29 Jul 2026
NSE Listed · Healthcare
Aatmaj Healthcare Limited (AATMAJ)
Volume: 0Avg Vol 1W: 4,400Avg Vol 1M: 6,18252W Range:₹16.7₹25.5
Key Ratios
Checked just nowMarket Cap₹60 Cr
Current Price₹18.5
Previous Close₹17.75
High / Low (52w)₹25.5 / ₹16.7
Volume0
Avg Vol (1W)4,400
Avg Vol (1M)6,182
Stock P/E231.25
Book Value₹8.75
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹0.08
P/B2.11
Debt / Equity—
50 DMA₹19.4
200 DMA₹20.58
Day change+4.23%
Price Chart
₹18.5▼ 2.63% · 1Y
2025-07-292026-07-29
20-day avg volume: 6K shares
Pros
- Revenue grew 26% YoY.
Cons
- Stock trades at a high P/E of 231.
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹3 Cr | ₹4 Cr | ₹17 Cr | ₹22 Cr | ₹27 Cr | ₹17 Cr | ₹21 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹7 Cr | ₹9 Cr | ₹3 Cr | ₹2 Cr |
| Net Profit | ₹-1 Cr | ₹0 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹1 Cr | ₹1 Cr |
| EPS | -1.62 | -0.5 | 7.63 | 37.41 | 3.64 | 0.39 | 0.28 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹11 Cr | ₹9 Cr | ₹10 Cr | ₹17 Cr | ₹31 Cr | ₹58 Cr | ₹63 Cr |
| Total Liabilities | ₹10 Cr | ₹10 Cr | ₹7 Cr | ₹9 Cr | ₹17 Cr | ₹8 Cr | ₹13 Cr |
| Equity | ₹1 Cr | ₹-1 Cr | ₹3 Cr | ₹8 Cr | ₹14 Cr | ₹49 Cr | ₹50 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹6 Cr | ₹8 Cr | ₹3 Cr | ₹-8 Cr | ₹3 Cr |
| Investing | ₹-1 Cr | ₹-3 Cr | ₹-1 Cr | ₹-8 Cr | ₹-1 Cr |
| Financing | ₹-5 Cr | ₹-7 Cr | ₹-4 Cr | ₹26 Cr | ₹-1 Cr |
| Free Cash Flow | ₹6 Cr | ₹8 Cr | ₹3 Cr | ₹-8 Cr | ₹3 Cr |
Shareholding
Promoter 64.33% Institutions 0% Public 35.67%
Efficiency & Working Capital
ROCE3.3%
Interest Coverage2.2
Dividend Payout—
Debtor Days459 d
Inventory Days13 d
Payable Days27 d
Cash Conversion Cycle445 d
Working Capital Days473 d
Shareholding Details
As of 2026-03-31
Promoter64.3%
FII0%
DII0%
Institutions0%
Public35.7%
Promoter Pledge0%
No. of Shareholders1,288
Shareholding Pattern
Quarterly — figures in %. Latest 9 quarters.
| Period | Mar 2023 | Jun 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 88.9% | 63.7% | 63.7% | 63.7% | 63.7% | 63.7% | 63.7% | 63.8% | 64.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.1% | 36.3% | 36.3% | 36.3% | 36.3% | 36.3% | 36.3% | 36.2% | 35.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9 | 2,511 | 1,772 | 1,537 | 1,522 | 1,409 | 1,389 | 1,350 | 1,288 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Tushar Karshanbhai Suvagiya | Shareholding of Promoter and Promoter Group | 46.7% | 1.06 Cr |
| Neomile Corporate Advisory Limited | Public Shareholding | 4.6% | 10,30,000 |
| Jignasa Tusharbhai Suvagiya | Shareholding of Promoter and Promoter Group | 4.1% | 9,24,000 |
| Jayshree Sanjay Kolambekar | Public Shareholding | 4% | 9,02,000 |
| Jitesh Narshibhai Suvagiya | Public Shareholding | 4% | 9,00,000 |
| Karshanbhai Jethabhai Suvagiya | Shareholding of Promoter and Promoter Group | 4% | 9,00,000 |
| Suvagiya Jayaben Karsanbhai | Shareholding of Promoter and Promoter Group | 4% | 9,00,000 |
| Ripal Subhash Padmani | Shareholding of Promoter and Promoter Group | 2% | 4,50,000 |
| Subhash Padmani | Shareholding of Promoter and Promoter Group | 2% | 4,50,000 |
| Ravi Arvind Apte | Shareholding of Promoter and Promoter Group | 1.6% | 3,60,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Tushar Suvagiya | Managing Director | 2025 |
| Jignasa Suvagiya | Whole-time Director | 2025 |
| Ravi Apte | Non Executive Director | 2025 |
| Jigneshkumar Gandhi | Independent Non Exe. Director | 2025 |
| Nirajkumar Lila | Independent Non Exe. Director | 2025 |
| Mansukh Patel | Independent Non Exe. Director | 2025 |
| Poorvi Gattani | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 12 | 11 | 11 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 10 | 0 | 10 |
| 2025 | 0 | 0 | 0 | 7 | 0 | 7 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
🌐 www.jupiterhospitalvadodara.com ↗
📍 JupiterHospital OppICAI Bhavan, Sunpharma Ataladra Road, Vadodara, Gujarat, 390012
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search